EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
166 hedge funds and large institutions have $574M invested in Eagle Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 50 increasing their positions, 70 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
166
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.22M | |
| 2 | +$5.09M | |
| 3 | +$3.12M | |
| 4 |
Two Sigma Investments
New York
|
+$2.49M |
| 5 |
SG Americas Securities
New York
|
+$1.73M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$5.16M | |
| 3 | -$4.15M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.14M |
| 5 |
Renaissance Technologies
New York
|
-$2.74M |